ArticleClinical medicine insights. Endocrinology and diabetes2024
Author Response to Comment on: "Benefit-Risk Assessment of ChatGPT Applications in the Field of Diabetes and Metabolic Illnesses: A Qualitative Study".
Ammar Abdulrahman Jairoun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.